These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6179635)

  • 21. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental allergic encephalomyelitis: activation of myelin basic protein-sensitized spleen cells by specific antigen in culture.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    Cell Immunol; 1981 Mar; 59(1):42-53. PubMed ID: 6163562
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
    Hayosh NS; Simon LL; Swanborg RH
    J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acquisition of encephalitogenicity after sensitized cells are conditioned with myelin basic protein or concanavalin A.
    Levine S; Abreu SL; Sowinski R
    Cell Immunol; 1985 Feb; 90(2):599-604. PubMed ID: 2578332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental allergic encephalomyelitis supernate transfer activity (EAE-STA) in Lewis rats: undiminished activity of immunoglobulin-depleted supernates and evidence for xenogeneic restriction.
    Whitacre CC; Paterson PY; Day ED; Bornstein MB
    Cell Immunol; 1981 Jul; 62(1):50-9. PubMed ID: 6973409
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental allergic encephalomyelitis (EAE)-changes in structure and proliferation in rat lymph nodes after sensitization with guinea-pig and bovine basic myelin protein.
    Matous-Malbohan I; Mares V; Lodin Z; Holub M
    Experientia; 1977 Apr; 33(4):533-4. PubMed ID: 67964
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
    Tabi Z; McCombe PA; Pender MP
    Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular bases for the difference in the potency of myelin basic protein from different species in Lewis rats.
    Hashim GA
    Adv Exp Med Biol; 1978; 100():289-301. PubMed ID: 80942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).
    Bolton C
    Agents Actions; 1992 Jan; 35(1-2):79-84. PubMed ID: 1380765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature of the defect in experimental allergic encephalomyelitis (EAE)-resistant Lewis (Le-R) rats.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1985 Mar; 134(3):1567-70. PubMed ID: 2578512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune effector cells. Part 10: Effector cells of autoimmune encephalomyelitis in healthy nonimmune rats.
    Hayosh NS; Silberg DG; Swanborg RH
    J Neuroimmunol; 1988 Jul; 18(4):315-24. PubMed ID: 2454945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats.
    Gausas J; Paterson PY; Day ED; Dal Canto MC
    Cell Immunol; 1982 Sep; 72(2):360-6. PubMed ID: 6185236
    [No Abstract]   [Full Text] [Related]  

  • 33. Myelin basic protein serum factor (MBP-SF) in adult Lewis rats: a method for detection and evidence that MBP-SF influences the appearance of antibody to MBP in animals developing experimental allergic encephalomyelitis.
    Day ED; Varitek VA; Paterson PY
    Immunochemistry; 1978 Jul; 15(7):437-42. PubMed ID: 81800
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of experimental allergic encephalomyelitis (EAE): suppression of active reinduction of EAE in rats recovered from passively transferred disease.
    Namikawa T; Kunishita T; Tabira T
    J Neuroimmunol; 1986 Sep; 12(3):235-45. PubMed ID: 2426304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins.
    MacPherson CF; Armstrong H
    Nature; 1977 Mar; 266(5601):459-61. PubMed ID: 67565
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of adoptive cell transfers in experimental allergic encephalomyelitis by antigen treatment of donors.
    Rauch HC
    Cell Immunol; 1981 May; 60(1):220-7. PubMed ID: 6165484
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells.
    Gonatas NK; Howard JC
    Science; 1974 Nov; 186(4166):839-41. PubMed ID: 4143378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of experimental allergic encephalomyelitis in Lewis rats by administration of gangliosides.
    Shimada K; Koh CS; Uemura K; Yanagisawa N
    Cell Immunol; 1994 Mar; 154(1):231-9. PubMed ID: 7509729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of complement in the pathogenesis of experimental allergic encephalomyelitis.
    Linington C; Morgan BP; Scolding NJ; Wilkins P; Piddlesden S; Compston DA
    Brain; 1989 Aug; 112 ( Pt 4)():895-911. PubMed ID: 2476195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.